Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Clinical Microbiology

• Publication date

  1985-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jcm.22.6.1050-1052.1985PMID 4066916PMCID PMC271877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Virus enzyme-linked cell immunoassay (VELCIA): detection and titration of rotavirus antigen and demonstration of rotavirus neutralizing and total antibodies.

  1985cited by this paper
• Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

  1985cited by this paper
• Efficiency of human rotavirus propagation in cell culture

  1984cited by this paper
• Titration of dengue viruses by immunofluorescence in microtiter plates

  1984cited by this paper
• Radioimmunofocus assay for detection and quantitation of human rotavirus

  1984cited by this paper
• Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures

  1983cited by this paper
• Antigenic and biological relationships between human coronavirus OC43 and neonatal calf diarrhoea coronavirus.

  1981cited by this paper
• Human rotavirus type 2: cultivation in vitro.

  1980cited by this paper
• Procedure for Fluorescent-Antibody Staining of Virus-Infected Cell Cultures in Plastic Plates

  1976cited by this paper
• Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.

  1957cited by this paper

• Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus

  2024cites this paper
• Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects

  2022cites this paper
• Rapid evaluation of neutralizing antibodies in COVID-19 patients

  2020cites this paper
• Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.

  2019cites this paper
• An optimized high-throughput fluorescence plate reader-based RSV neutralization assay.

  2018cites this paper
• Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection.

  2018cites this paper
• Case study-based time-course analysis of symptoms of respiratory syncytial virus infections followed by acute sinusitis in otherwise-healthy adults.

  2018cites this paper
• Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

  2017cites this paper
• Development of a novel rapid micro-neutralization ELISA for the detection of neutralizing antibodies against Chandipura virus.

  2017cites this paper
• Comparison of serological assays to titrate Hantaan and Seoul hantavirus-specific antibodies

  2017cites this paper
• The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years

  2017cites this paper
• Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection

  2016cites this paper
• Acute viral respiratory infections among children in MERS‐endemic Riyadh, Saudi Arabia, 2012–2013

  2016cites this paper
• An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.

  2015cites this paper
• An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein

  2015cites this paper
• CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

  2015cites this paper
• Prophylaxis with a Respiratory Syncytial Virus (RSV) Anti-G Protein Monoclonal Antibody Shifts the Adaptive Immune Response to RSV rA2-line19F Infection from Th2 to Th1 in BALB/c Mice

  2014cites this paper
• Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

  2014cites this paper
• A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults

  2013cites this paper
• A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment

  2013cites this paper
• immunoassay.virus proteins by competitive binding Identification of epitopes on respiratory

  2013cites this paper
• Detection of respiratory syncytial virus fusion protein variants between 2009 and 2012 in China

  2013cites this paper
• Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses

  2013cites this paper
• A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

  2013cites this paper
• Translational sciences approach to RSV vaccine development

  2013cites this paper
• A respiratory syncytial virus isolate enables the testing of virucidal products.

  2012cites this paper
• An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting

  2012cites this paper
• Registration of influenza vaccines for children in Europe.

  2011cites this paper
• Diagnosis of Respiratory Syncytial Virus Infection

  2011cites this paper
• Monomeric and Dimeric IgG Fractions Show Differential Reactivity Against Pathogen‐Derived Antigens

  2011cites this paper
• A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate.

  2010cites this paper
• Propagation and Identification of Viruses

  2010cites this paper
• Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71.

  2010cites this paper
• Palivizumab-resistant human respiratory syncytial virus infection in infancy.

  2010cites this paper
• RSV fusion (F) protein DNA vaccine provides partial protection against viral infection.

  2009cites this paper
• Microneutralization assay for the measurement of neutralizing antibodies to human metapneumovirus.

  2009cites this paper
• Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus.

  2009cites this paper
• Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.

  2009cites this paper
• Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab.

  2008cites this paper
• Virus isolation and quantitation

  2007cites this paper
• Pulmonary complications of interpandemic influenza A in hospitalized adults.

  2006influential citation
• Time-resolved fluoroimmunoassays with monoclonal antibodies for rapid identification of parainfluenza type 4 and mumps viruses

  2005cites this paper
• Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.

  2005cites this paper
• In Vivo Selection of Respiratory Syncytial Viruses Resistant to Palivizumab

  2005cites this paper
• Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats.

  2004cites this paper
• Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.

  2004cites this paper
• Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants.

  2004cites this paper
• Elevations of local leukotriene C4 levels during viral upper respiratory tract infections.

  2003cites this paper
• Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults.

  2003cites this paper
• Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique

  2002cites this paper
• Expression of beta-galactosidase by recombinant respiratory syncytial viruses for microneutralization assay.

  2002cites this paper
• Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses.

  2002cites this paper
• Anticorps reconnaissant la protein f du virus respiratoire syncytial (rsv)

  2001cites this paper
• Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge

  2001cites this paper
• Evaluation of an early two-dose measles vaccination schedule.

  2001cites this paper
• Antiviral activity of NMSO 3 against respiratory syncytial virus infection in vitro and in vivo

  2000cites this paper
• Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.

  2000cites this paper
• Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.

  2000cites this paper
• A microtitre plate method for isolation and typing of poliovirus using a blue-cell ELISA.

  2000cites this paper
• Respiratory Syncytial Virus Infects the Bonnet Monkey, Macaca radiata

  1999cites this paper
• Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus.

  1999cites this paper
• Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.

  1999cites this paper
• A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.

  1999cites this paper
• Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease

  1998cites this paper
• Adverse impact of infections on antibody responses to measles vaccination.

  1998cites this paper
• Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults.

  1998cites this paper
• Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group.

  1998cites this paper
• Respiratory syncytial virus infection in older persons.

  1998cites this paper
• Pediatric Investigators Collaborative Network on Infections in Canada ) Study of the Role of Age and Respiratory Syncytial Virus Neutralizing Antibody on Respiratory Syncytial Virus Illness in Patients With Underlying Heart or Lung Disease

  1997cites this paper
• Experimental measles. II. Infection and immunity in the rhesus macaque.

  1997cites this paper
• Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

  1997cites this paper
• Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections.

  1997cites this paper
• Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly.

  1997cites this paper
• Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

  1997cites this paper
• Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections

  1997cites this paper
• Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.

  1996cites this paper
• Advances in the diagnosis of respiratory virus infections

  1996cites this paper
• An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.

  1996cites this paper
• Stabilization of respiratory syncytial virus (RSV) against thermal inactivation and freeze-thaw cycles for development and control of RSV vaccines and immune globulin.

  1996cites this paper
• Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern

  1996influential citation
• Characteristics of IL‐6 and TNF‐α production by respiratory syncytial virus‐infected macrophages in the neonate

  1996cites this paper
• An evaluation of measles revaccination among school-entry-aged children.

  1996cites this paper
• Development and Application of a Microneutralization ELISA for the Detection of Antibodies to Bovine Respiratory Syncytial Viruses

  1995cites this paper
• Different kinetics of antibody responses between IgA and IgG classes in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection

  1995cites this paper
• Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections

  1995cites this paper
• Antigen detection in human respiratory Coronavirus infections by monoclonal time-resolved fluoroimmunoassay

  1994cites this paper
• Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells.

  1994cites this paper
• Neutralization enzyme immunoassay for influenza virus

  1994cites this paper
• Neutralization EnzymeImmunoassay forInfluenza Virus

  1994cites this paper
• Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement.

  1994cites this paper
• Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice.

  1993cites this paper
• Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children.

  1993cites this paper
• Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

  1993cites this paper
• Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection

  1993cites this paper
• Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay.

  1992cites this paper
• A novel, spectrophotometric microneutralization assay for respiratory syncytial virus.

  1992cites this paper
• Humoral immunity to respiratory syncytial virus infection in the elderly

  1992cites this paper
• Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line

  1991cites this paper
• Immunity to and frequency of reinfection with respiratory syncytial virus.

  1991cites this paper
• Antibody Enhancement ofRespiratory Syncytial VirusStimulation ofLeukotriene Production byaMacrophagelike CellLine

  1991cites this paper